13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001694297
Total reported value
$104.7M
$104.7M
21 檔
123.3%
At the close of Q3 2025, 22nw, LP disclosed equity holdings valued at approximately $104.7M, spread across 21 reported holdings.
22nw, LP executed strategic sector rebalancing during Q3 2025, establishing 7 new positions while fully exiting 6 holdings and trimming 3 positions.
In terms of portfolio concentration, the top 5 core holdings (including ANEB, FSTR, LFCR) accounted for 123.3% of total reported equity market value during Q3 2025.
Top New Position Initiated
NKTR
市值: $18.8M
Top Position Liquidated / Trimmed
STRL
前期市值: $11.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ANEB | Anebulo Pharmaceuticals Inc | Stock-Other | 18.22% | — | — | |
| 2 | FSTR | Foster (lb) Co-a | Stock-Other | 16.67% | -20.41% | EXIT | |
| 3 | LFCR | Lifecore Biomedical Inc | Stock-Other | 9.49% | -12.92% | -99.53% | |
| 4 | NKTR | Nektar Therapeutics | Stock-Other | 8.88% | +4.89% | +126.61% | |
| 5 | SRI | Stoneridge Inc | Stock-Other | 7.56% | +9.08% | +8.34% | |
| 6 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 6.40% | -5.32% | -36.02% | |
| 7 | RGNX | Regenxbio Inc | Stock-Other | 4.20% | +2.81% | — | |
| 8 | CULP | Culp Inc | Stock-Other | 3.91% | +2.02% | — | |
| 9 | RZLT | Rezolute Inc | Stock-Other | 3.63% | +2.36% | — | |
| 10 | DHX | Dhi Group Inc | Stock-Other | 2.67% | — | -38.27% | |
| 11 | PFX | Phenixfin CORP | Stock-Other | 2.64% | -1.15% | EXIT | |
| 12 | MEC | Mayville Engineering Co Inc | Stock-Other | 2.59% | — | +157.25% | |
| 13 | MGTX | MeiraGTx Holdings plc | Stock-Other | 2.27% | — | — | |
| 14 | UFI | Unifi Inc | Stock-Other | 2.19% | +1.78% | -0.40% | |
| 15 | CMT | Core Molding Technologies In | Stock-Other | 2.16% | +2.75% | +16.48% | |
| 16 | ✓ | Aebi Schmidt Hldg AG | Stock-Other | 2.04% | — | — | |
| 17 | FB1 | Farmer Bros Co | Stock-Other | 1.58% | -1.70% | EXIT | |
| 18 | TISI | Team Inc | Stock-Other | 1.33% | +0.95% | -0.53% | |
| 19 | ELDN | Eledon Pharmaceuticals Inc | Stock-Other | 0.78% | +1.06% | — | |
| 20 | SSKN | Strata Skin Sciences Inc | Stock-Other | 0.52% | — | — | |
| 21 | PMDI | Psychemedics CORP | Stock-Other | 0.27% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ANEB | Anebulo Pharmaceuticals Inc | +4.7% | — | Unchanged |
| 2 | SRI | Stoneridge Inc | +2.6% | +8.34% | Add |
| 3 | MLYS | Mineralys Therapeutics Inc | +1.5% | -36.02% | Trim |
| 4 | RGNX | Regenxbio Inc | +1% | — | Add |
| 5 | TISI | Team Inc | +0.9% | -0.53% | Add |
| 6 | DHX | Dhi Group Inc | +0.2% | -38.27% | Trim |
| 7 | UFI | Unifi Inc | -0.2% | -0.40% | Add |
| 8 | SSKN | Strata Skin Sciences Inc | -0.4% | — | Unchanged |
| 9 | FSTR | Foster (lb) Co-a | -0.7% | — | Unchanged |
| 10 | ELDN | Eledon Pharmaceuticals Inc | -0.7% | — | Unchanged |
| 11 | FB1 | Farmer Bros Co | -1.3% | — | Unchanged |
| 12 | PFX | Phenixfin CORP | -1.6% | — | Unchanged |
| 13 | CULP | Culp Inc | -2.3% | — | Unchanged |
| 14 | LFCR | Lifecore Biomedical Inc | -10.5% | -99.53% | Trim |
| 15 | NKTR | Nektar Therapeutics | — | NEW | New buy |
| 16 | STRL | Sterling Infrastructure Inc | — | EXIT | Sold out |
| 17 | RZLT | Rezolute Inc | — | NEW | New buy |
| 18 | MEC | Mayville Engineering Co Inc | — | NEW | New buy |
| 19 | BBSI | Barrett Business Svcs Inc | — | EXIT | Sold out |
| 20 | MGTX | MeiraGTx Holdings plc | — | NEW | New buy |
| 21 | CMT | Core Molding Technologies In | — | NEW | New buy |
| 22 | ✓ | Aebi Schmidt Hldg AG | — | NEW | New buy |
| 23 | CMPS | Compass Pathways PLC | — | EXIT | Sold out |
| 24 | KROS | Keros Therapeutics Inc | — | EXIT | Sold out |
| 25 | NKTREUR | Nektar Therapeutics | — | EXIT | Sold out |
| 26 | PMDUSD | Psychemedics CORP | — | EXIT | Sold out |
| 27 | PMDI | Psychemedics CORP | — | NEW | New buy |
According to official SEC Form 13F filings, 22nw, LP reported a total U.S. public equity portfolio value of $104.7M across 21 disclosed positions in Q3 2025.
During Q3 2025, 22nw, LP's top holdings by market value included ANEB (18.2%)、FSTR (16.7%)、LFCR (9.5%). The largest single position, ANEB, represented 18.2% of total portfolio value.
In Q3 2025, 22nw, LP made 20 total portfolio adjustments, initiating 7 new buys, adding to 4 positions, trimming 3 holdings, and fully liquidating 6 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.